New Zealand markets close in 4 hours 41 minutes

Instil Bio, Inc. (TIL)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
10.75+0.04 (+0.37%)
At close: 04:00PM EDT
10.50 -0.25 (-2.33%)
After hours: 04:07PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close10.71
Bid0.00 x 0
Ask0.00 x 0
Day's range10.75 - 10.78
52-week range6.08 - 14.00
Avg. volume18,367
Market cap69.917M
Beta (5Y monthly)1.25
PE ratio (TTM)N/A
EPS (TTM)-24.00
Earnings date09 May 2024 - 13 May 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est27.67
  • Zacks

    What Makes Instil Bio (TIL) a New Buy Stock

    Instil Bio (TIL) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

  • GlobeNewswire

    Instil Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update

    DALLAS, March 21, 2024 (GLOBE NEWSWIRE) -- Instil Bio, Inc. (“Instil”) (Nasdaq: TIL), a clinical-stage biopharmaceutical company focused on developing a pipeline of novel therapies, today reported its fourth quarter and full year 2023 financial results and provided a corporate update. Recent Highlights: Announced entering into a strategic collaboration to develop an autologous folate receptor α (FRα)-CoStAR enhanced TIL for a potential investigator-initiated trial (IIT) in non-small cell lung ca

  • Zacks

    Instil (TIL) Stock Rises More Than 20% in a Week: Here's Why

    Instil's (TIL) recent deal with a collaborator to carry out preclinical manufacturing feasibility studies on its ITIL-306 program is a positive.